These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 17400535

  • 1. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
    Mohler J, Moine P, Azoulay-Dupuis E, Henin D, Fantin B.
    Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains.
    Ferreira DM, Moreno AT, Cianciarullo AM, Ho PL, Oliveira ML, Miyaji EN.
    Microb Pathog; 2009 Sep; 47(3):157-63. PubMed ID: 19467320
    [Abstract] [Full Text] [Related]

  • 3. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 4. Nuclear factor-kappaB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection.
    Amory-Rivier CF, Mohler J, Bédos JP, Azoulay-Dupuis E, Henin D, Muffat-Joly M, Carbon C, Moine P.
    Crit Care Med; 2000 Sep; 28(9):3249-56. PubMed ID: 11008989
    [Abstract] [Full Text] [Related]

  • 5. Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: otitis media and acute pneumonia.
    Cripps AW, Kyd JM.
    Vaccine; 2007 Mar 22; 25(13):2471-7. PubMed ID: 17110001
    [Abstract] [Full Text] [Related]

  • 6. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
    Ferreira DM, Darrieux M, Oliveira ML, Leite LC, Miyaji EN.
    Clin Vaccine Immunol; 2008 Mar 22; 15(3):499-505. PubMed ID: 18184825
    [Abstract] [Full Text] [Related]

  • 7. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
    Xu Q, Surendran N, Verhoeven D, Klapa J, Ochs M, Pichichero ME.
    Vaccine; 2015 Feb 18; 33(8):993-1000. PubMed ID: 25597944
    [Abstract] [Full Text] [Related]

  • 8. Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia.
    Mohler J, Azoulay-Dupuis E, Amory-Rivier C, Mazoit JX, Bédos JP, Rieux V, Moine P.
    Intensive Care Med; 2003 May 18; 29(5):808-16. PubMed ID: 12665994
    [Abstract] [Full Text] [Related]

  • 9. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L, Jeurissen A, Mittler RS, Wuyts G, Michiels G, Boon L, Ceuppens JL, Bossuyt X.
    J Leukoc Biol; 2007 Sep 18; 82(3):638-44. PubMed ID: 17550973
    [Abstract] [Full Text] [Related]

  • 10. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A, Metzger DW.
    Vaccine; 2006 Jul 07; 24(27-28):5584-92. PubMed ID: 16730398
    [Abstract] [Full Text] [Related]

  • 11. Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-γ-mediated immunity.
    Marqués JM, Rial A, Muñoz N, Pellay FX, Van Maele L, Léger H, Camou T, Sirard JC, Benecke A, Chabalgoity JA.
    Immunobiology; 2012 Apr 07; 217(4):420-9. PubMed ID: 22204818
    [Abstract] [Full Text] [Related]

  • 12. Enhanced immediate inflammatory response to Streptococcus pneumoniae in the lungs of mice with pulmonary emphysema.
    Tokairin Y, Shibata Y, Sata M, Abe S, Takabatake N, Igarashi A, Ishikawa T, Inoue S, Kubota I.
    Respirology; 2008 May 07; 13(3):324-32. PubMed ID: 18399852
    [Abstract] [Full Text] [Related]

  • 13. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E, Jakobsen H, Ingolfsdottir G, Sigurdardottir ST, Jonsdottir I.
    J Infect Dis; 2001 Jan 15; 183(2):253-260. PubMed ID: 11110649
    [Abstract] [Full Text] [Related]

  • 14. Intranasal Immunization with the Commensal Streptococcus mitis Confers Protective Immunity against Pneumococcal Lung Infection.
    Shekhar S, Khan R, Schenck K, Petersen FC.
    Appl Environ Microbiol; 2019 Mar 15; 85(6):. PubMed ID: 30683742
    [Abstract] [Full Text] [Related]

  • 15. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, Shan Y, Yin Y.
    Vaccine; 2007 Jun 28; 25(27):4996-5005. PubMed ID: 17524530
    [Abstract] [Full Text] [Related]

  • 16. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM, Lo Passo C, Scuderi A, Kolberg J, Baxendale H, Goldblatt D, Oggioni MR, Felici F, Andrew PW.
    Eur J Immunol; 2009 Jun 28; 39(6):1527-35. PubMed ID: 19499518
    [Abstract] [Full Text] [Related]

  • 17. Azithromycin modulates murine immune responses to pneumococcal conjugate vaccine and inhibits nasal clearance of bacteria.
    Fernandez AD, Elmore MK, Metzger DW.
    J Infect Dis; 2004 Nov 15; 190(10):1762-6. PubMed ID: 15499531
    [Abstract] [Full Text] [Related]

  • 18. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.
    Kirkham LA, Kerr AR, Douce GR, Paterson GK, Dilts DA, Liu DF, Mitchell TJ.
    Infect Immun; 2006 Jan 15; 74(1):586-93. PubMed ID: 16369015
    [Abstract] [Full Text] [Related]

  • 19. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia.
    Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ.
    J Immunol; 1995 Jul 15; 155(2):722-9. PubMed ID: 7608550
    [Abstract] [Full Text] [Related]

  • 20. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection.
    Kafka D, Ling E, Feldman G, Benharroch D, Voronov E, Givon-Lavi N, Iwakura Y, Dagan R, Apte RN, Mizrachi-Nebenzahl Y.
    Int Immunol; 2008 Sep 15; 20(9):1139-46. PubMed ID: 18596024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.